Recombinant antihemophilic factor, plasma/albumin-free method (rAHF-PFM)
061002
Phase 3 mab terminated
Quick answer
Recombinant antihemophilic factor, plasma/albumin-free method (rAHF-PFM) for Hemophilia A is a Phase 3 program (mab) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Hemophilia A
- Phase
- Phase 3
- Modality
- mab
- Status
- terminated